|
Summary:
the customer "[(b)(6), usa]" reported potential false-negative results on the biofire blood culture identification 2 (bcid2) panel after testing patient samples.Due to the bcid2 panel results, 2 of the 3 patients were indirectly impacted, specifically by a delay in care, which might lead to serious injury if it were to recur.1 of the 3 patients was not reported to have been affected.No patient harm was reported.The customer stated that 2 of the 3 patients were affected, but did not specify which patients were impacted ((b)(6) male, 78-year-old male, or 80-year-old female).The following potential discrepant results were reported:
patient #1: false negative e.Coli;
patient #2: false negative p.Aeruginosa;
patient #3: false negative p.Mirabilis.Please note two mdrs will be submitted, one for each affected patient.This mdr pertains to the second affected patient.Biofire has requested further information from the customer and is currently investigating this event.No remedial action, corrective action, preventive action, or field safety corrective action (fsca) has been deemed necessary at this time.
|